441 related articles for article (PubMed ID: 29725697)
21. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
Artemenko Y; Gagnon A; Sorisky A
J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
[TBL] [Abstract][Full Text] [Related]
22. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP
Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022
[TBL] [Abstract][Full Text] [Related]
23. Peruvoside targets apoptosis and autophagy through MAPK Wnt/β-catenin and PI3K/AKT/mTOR signaling pathways in human cancers.
Reddy D; Kumavath R; Tan TZ; Ampasala DR; Kumar AP
Life Sci; 2020 Jan; 241():117147. PubMed ID: 31830480
[TBL] [Abstract][Full Text] [Related]
24. [The mechanism for SHIP gene to induce the apoptosis of human leukemia cell line K562.].
Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L; Yang JC
Sheng Li Xue Bao; 2009 Apr; 61(2):146-54. PubMed ID: 19377826
[TBL] [Abstract][Full Text] [Related]
25. Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer.
Zhang L; Zhou F; ten Dijke P
Trends Biochem Sci; 2013 Dec; 38(12):612-20. PubMed ID: 24239264
[TBL] [Abstract][Full Text] [Related]
26. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
[TBL] [Abstract][Full Text] [Related]
27. Human T-cell leukemia virus type I tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-kappaB pathway.
Fukuda RI; Tsuchiya K; Suzuki K; Itoh K; Fujita J; Utsunomiya A; Tsuji T
J Biol Chem; 2009 Jan; 284(5):2680-2689. PubMed ID: 19047050
[TBL] [Abstract][Full Text] [Related]
28. miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer.
Strotbek M; Schmid S; Sánchez-González I; Boerries M; Busch H; Olayioye MA
Int J Cancer; 2017 May; 140(10):2310-2320. PubMed ID: 28224609
[TBL] [Abstract][Full Text] [Related]
29. Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155.
Lee DW; Futami M; Carroll M; Feng Y; Wang Z; Fernandez M; Whichard Z; Chen Y; Kornblau S; Shpall EJ; Bueso-Ramos CE; Corey SJ
Oncogene; 2012 Sep; 31(37):4085-94. PubMed ID: 22249254
[TBL] [Abstract][Full Text] [Related]
30. PTEN and Other PtdIns(3,4,5)P
Csolle MP; Ooms LM; Papa A; Mitchell CA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
[TBL] [Abstract][Full Text] [Related]
31. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
Moench R; Grimmig T; Kannen V; Tripathi S; Faber M; Moll EM; Chandraker A; Lissner R; Germer CT; Waaga-Gasser AM; Gasser M
Oncotarget; 2016 Oct; 7(42):68749-68767. PubMed ID: 27626684
[TBL] [Abstract][Full Text] [Related]
32. Role of SHIP1 in cancer and mucosal inflammation.
Fernandes S; Iyer S; Kerr WG
Ann N Y Acad Sci; 2013 Mar; 1280(1):6-10. PubMed ID: 23551094
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer.
Wright TD; Raybuck C; Bhatt A; Monlish D; Chakrabarty S; Wendekier K; Gartland N; Gupta M; Burow ME; Flaherty PT; Cavanaugh JE
J Cell Biochem; 2020 Feb; 121(2):1156-1168. PubMed ID: 31464004
[TBL] [Abstract][Full Text] [Related]
34. Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motility.
Harris SJ; Parry RV; Foster JG; Blunt MD; Wang A; Marelli-Berg F; Westwick J; Ward SG
J Immunol; 2011 Apr; 186(8):4936-45. PubMed ID: 21402888
[TBL] [Abstract][Full Text] [Related]
35. Phosphatidylinositol Phosphate 5-Kinase Iγ and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth.
Thapa N; Choi S; Tan X; Wise T; Anderson RA
J Biol Chem; 2015 Jul; 290(30):18843-54. PubMed ID: 26070568
[TBL] [Abstract][Full Text] [Related]
36. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
[TBL] [Abstract][Full Text] [Related]
37. Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway.
Lessmann E; Grochowy G; Weingarten L; Giesemann T; Aktories K; Leitges M; Krystal G; Huber M
Exp Hematol; 2006 Nov; 34(11):1532-41. PubMed ID: 17046573
[TBL] [Abstract][Full Text] [Related]
38. PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway.
Wang S; Cheng Z; Cui Y; Xu S; Luan Q; Jing S; Du B; Li X; Li Y
J Transl Med; 2023 Nov; 21(1):819. PubMed ID: 37974250
[TBL] [Abstract][Full Text] [Related]
39. Phosphatidylinositolphosphate phosphatase activities and cancer.
Rudge SA; Wakelam MJ
J Lipid Res; 2016 Feb; 57(2):176-92. PubMed ID: 26302980
[TBL] [Abstract][Full Text] [Related]
40. The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis.
Ooms LM; Binge LC; Davies EM; Rahman P; Conway JR; Gurung R; Ferguson DT; Papa A; Fedele CG; Vieusseux JL; Chai RC; Koentgen F; Price JT; Tiganis T; Timpson P; McLean CA; Mitchell CA
Cancer Cell; 2015 Aug; 28(2):155-69. PubMed ID: 26267533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
